A new study published in a peer-reviewed journal concludes that the shingles vaccine can significantly reduce the risk of dementia. This supports a previous study that shows a similar reduction in risk. In addition, there is some evidence that infectious diseases, such as shingles, may increase the risk of dementia and Alzheimer’s disease.
This does not imply that the shingles vaccine eliminates the risk of dementia, but it provides strong evidence that the risk is reduced.
As I usually do, I will review the findings of this new research and provide an analysis of what it may say.

What are shingles?
One of the consequences of contracting chickenpox, caused by a virus called Varicella zoster, is that the body’s immune system does not destroy the virus. Once the symptoms of chickenpox disappear, the virus hides (it does not do this consciously, it’s a virus) in the dorsal root ganglion, a bundle of nerve fibers at the bottom of the spinal column. The virus hangs out there, hidden from the body’s immune system.
We are not sure why it does this, but it may be an evolutionary adaptation to survive until later so that it can reproduce and reinfect the victim.
Even though the body generated an immune response to the original zoster virus infection, several years or decades after the initial infection, the adaptive immune response against the virus wanes or disappears. Due to other unknown factors, possibly stress or other infections like COVID-19, the Varicella zoster virus “moves” along the nerve bundles and begins a secondary infection with much more serious consequences to the individual.
This second infection is called herpes zoster, more commonly known as shingles. This infection usually happens when the patient is older than 50, although it can happen at any time, occasionally even in young adults.
Despite both chickenpox and shingles being caused by the same virus, shingles were given a different name, herpes zoster, probably because it was originally thought to be caused by a similar, but unrelated virus. However, herpes zoster is not a formal name based on biological binomial nomenclature. We now know that the virus Varicella zoster causes both chickenpox and shingles.
What can be said about shingles is that it’s an entirely unpredictable disease. It appears at random points in time in response to unknown variables. Once shingles appear, it is painful, depending on the location of the outbreak. It can cause blindness, disfigurement of the infected area, permanent pain, and other conditions.
Shingles can be treated with antiviral drugs, but only if the infection is recognized and treated within 24-72 hours, a time frame that might not allow most individuals to get to their doctor. The initial symptoms may appear like acne or other skin conditions, which many people might ignore. After 72 hours, the disease has to run its painful and dangerous course. The pain of shingles may last for weeks, months, or even years after the blisters have healed – this is not a trivial disease.
The only way to prevent a shingles infection is to boost the immune system with a new vaccine against the zoster virus. Shingrix (a shingles vaccine, sometimes called the zoster vaccine, available in the USA) is a relatively new, safe, and effective vaccine.
There is one other way to prevent shingles — never get chickenpox in the first place. And we have a vaccine for that, the chickenpox (or varicella) vaccine.
So let’s be clear about a couple of things. First, you are only at risk for shingles if you contract chickenpox. Second, children who have received the chickenpox vaccine should never contract shingles.
What is dementia?
Dementia is a term that covers a wide range of chronic, age-related neurodegenerative diseases including Alzheimer’s disease, Lewy body dementia, frontotemporal disorders, vascular dementia, and mixed dementia, which is a combination of two or more of the different forms of dementia. Alzheimer’s disease accounts for approximately 60-70% of dementia cases, but people occasionally use dementia to describe Alzheimer’s disease.
The causes of the various forms of dementia are not widely understood and there are no simple cures for them. There may be modifiable lifestyle factors that can reduce the risk of dementia, but there are no guaranteed methods to prevent it.

Shingles vaccine and dementia risk paper
In a paper published on 25 July 2024 in Nature Medicine, Maxime Taquet, PhD, of the University of Oxford, England, and colleagues used the US-based TriNetX electronic health records database to study 103,837 individuals ages 65 and older who received a first dose of shingles vaccine between November 2017 and October 2020; 95% received the recombinant vaccine (Shingrix®). These older adults were propensity-score matched with 103,837 individuals who received their first dose between October 2014 and September 2017 (98% had the live vaccine, which is no longer recommended in the USA). People with previous diagnoses of dementia or neurodegenerative disease were excluded from the study.
Median follow-up was 4.15 years in the recombinant vaccine group and 6.0 years in the live vaccine group. The primary outcome was a first diagnosis of dementia from 3 months (to exclude possible pre-existing dementia) to 6 years post-vaccination in a time-to-event analysis, based on ICD-10 codes.
Here are the key results:
- Over a 6-year follow-up period, adults who predominantly received the recombinant herpes zoster vaccine had a 17% increase in time without a dementia diagnosis.
- This translated into 164 additional days without a dementia diagnosis.
The authors concluded:
The recombinant shingles vaccine was also associated with lower risks of dementia compared to two other vaccines commonly used in older people: influenza and tetanus/diphtheria/pertussis vaccines. The effect was robust across multiple secondary analyses, and present in both men and women but greater in women.
Summary
This study showed a significantly lower risk of dementia for individuals who received the recombinant shingles vaccine. Preventing shingles, a painful and disfiguring disease, is the primary goal of the vaccine, but if it can reduce the risk or increase the time to a dementia diagnosis, that makes the vaccine even more valuable.
So why might the shingles vaccine have this effect on dementia?
As I mentioned at the top, several studies have linked viral illnesses with an increased risk of developing dementia. Another study has shown that human herpesvirus 6A and human herpesvirus 7, both of which are closely related to the Varicella zoster virus that causes shingles, have been found in postmortem tissue taken from people with Alzheimer’s disease at levels up to twice as high as non-Alzheimer’s disease samples.
Based on the growing evidence of a link between viral infections and dementia (especially Alzheimer’s disease), a clinical study is underway to determine whether the antiviral drug, valacyclovir, can be used to treat Alzheimer’s disease.
Of course, more studies need to be completed to provide us with more data to show that the shingles vaccine does indeed reduce the risk of dementia and Alzheimer’s disease. I am looking forward to this additional data, but at this time, given the benefits of the shingles vaccine, it’s worth getting it.
Citations
- Levine KS, Leonard HL, Blauwendraat C, Iwaki H, Johnson N, Bandres-Ciga S, Ferrucci L, Faghri F, Singleton AB, Nalls MA. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029. Epub 2023 Jan 19. PMID: 36669485; PMCID: PMC10079561.
- Readhead B, Haure-Mirande JV, Funk CC, Richards MA, Shannon P, Haroutunian V, Sano M, Liang WS, Beckmann ND, Price ND, Reiman EM, Schadt EE, Ehrlich ME, Gandy S, Dudley JT. Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. 2018 Jul 11;99(1):64-82.e7. doi: 10.1016/j.neuron.2018.05.023. Epub 2018 Jun 21. PMID: 29937276; PMCID: PMC6551233.
- Sipilä PN, Heikkilä N, Lindbohm JV, Hakulinen C, Vahtera J, Elovainio M, Suominen S, Väänänen A, Koskinen A, Nyberg ST, Pentti J, Strandberg TE, Kivimäki M. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis. 2021 Nov;21(11):1557-1567. doi: 10.1016/S1473-3099(21)00144-4. Epub 2021 Jun 21. PMID: 34166620; PMCID: PMC8592915.
- Taquet M, Dercon Q, Todd JA, Harrison PJ. The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med. 2024 Jul 25. doi: 10.1038/s41591-024-03201-5. Epub ahead of print. PMID: 39053634.
Discover more from Skeptical Raptor
Subscribe to get the latest posts sent to your email.
